NYMXF · Nymox Pharmaceutical Corp · Documents
Market Cap
$3.36M
Shares
105.04M
Volume · Oct 20
6805
Avg daily vol (3M)
12.89K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| F-3 | — | 2022-03-29 | — | |
| 6-K | — | 2022-03-22 | — | |
| F-3 | — | 2021-12-09 | — | |
| 6-K/A | — | 2021-11-22 | 2021-11-19 | |
| 6-K | — | 2021-11-19 | — | |
| 6-K | — | 2021-11-12 | 2021-09-30 | |
| 6-K | — | 2021-08-13 | 2021-06-30 | |
| 20-F/A | — | 2021-06-11 | 2020-12-31 | |
| 6-K | — | 2021-05-14 | 2021-03-31 | |
| F-3 | — | 2021-05-12 | — | |
| 6-K | — | 2021-05-06 | 2021-04-30 | |
| 20-F | — | 2021-03-29 | 2020-12-31 | |
| 6-K | — | 2020-11-20 | 2020-11-19 | |
| 6-K | — | 2020-11-19 | 2020-11-18 | |
| 6-K | — | 2020-11-13 | 2020-09-30 | |
| 6-K | — | 2020-10-13 | — | |
| 6-K | — | 2020-08-14 | 2020-06-30 | |
| 6-K | — | 2020-08-14 | — | |
| 6-K | — | 2020-08-13 | 2020-08-11 | |
| 6-K | — | 2020-08-12 | — | |
| 6-K | — | 2020-07-20 | 2020-07-17 | |
| 6-K | — | 2020-05-14 | 2020-03-31 | |
| F-3/A | — | 2020-05-06 | — | |
| 6-K | — | 2020-04-24 | 2020-04-23 | |
| F-3/A | — | 2020-04-24 | — | |
| F-3 | — | 2020-04-03 | — | |
| 20-F | — | 2020-03-30 | 2019-12-31 |
Showing 51–77 of 77 filings